FindTrial
Sign In

ABVD

DRUG8 trials

Sponsors

Fondazione Italiana Linfomi - ETS, American Scitech International, Alliance for Clinical Trials in Oncology, UNC Lineberger Comprehensive Cancer Center, University of Modena and Reggio Emilia

Conditions

Advanced Hodgkin's LymphomaClassical Hodgkin LymphomaHodgkin DiseaseHodgkin LymphomaHodgkin Lymphoma (Category)Hodgkin Lymphoma, AdultHodgkin's DiseaseHodgkin's Lymphoma

Phase 2

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients
CompletedNCT00784537
Fondazione Italiana Linfomi - ETSHodgkin's Lymphoma
Start: 2008-09-30End: 2016-01-31Updated: 2018-02-08
Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease
NCT00797472
American Scitech InternationalHodgkin's Disease
Start: 2011-07-31End: 2014-04-30Target: 120Updated: 2011-07-20
Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
CompletedNCT01118026
Alliance for Clinical Trials in OncologyLymphoma
Start: 2010-09-30End: 2021-09-29Updated: 2021-12-01
Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma
NCT02275598
University of Modena and Reggio EmiliaHodgkin Lymphoma
Start: 2013-04-30End: 2015-03-31Updated: 2014-10-27
OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy
NCT03527628
King Abdullah International Medical Research CenterClassical Hodgkin Lymphoma, Hodgkin Disease, Hodgkin Lymphoma +1
Start: 2018-01-01End: 2022-01-15Target: 220Updated: 2019-11-18

Phase 3

Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma
NCT00816959
American Scitech InternationalHodgkin's Lymphoma
Start: 2011-07-31End: 2014-04-30Target: 1200Updated: 2011-07-20

Unknown Phase

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma
CompletedNCT01578967
UNC Lineberger Comprehensive Cancer CenterHodgkin Lymphoma, Adult
Start: 2012-04-30End: 2020-12-11Updated: 2021-12-07
Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial Protocol
NCT02800447
Lee's Pharmaceutical LimitedAdvanced Hodgkin's Lymphoma
Start: 2016-06-30End: 2018-12-31Updated: 2018-09-04

Related Papers

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial
Blood Advances2021-10-0129 citations
CALGB 50801 (Alliance): PET adapted therapy in bulky stage I/II classic Hodgkin lymphoma (cHL).
Journal of Clinical Oncology2021-05-207 citations
ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma
Blood Advances2020-06-0927 citations
BRENTUXIMAB VEDOTIN CONSOLIDATION TO REDUCE RADIATION USE IN PATIENTS WITH LIMITED STAGE NON‐BULKY HODGKIN LYMPHOMA: AN UPDATE FROM a PHASE 2 CLINICAL TRIAL
Hematological Oncology2017-06-017 citations
A phase 2 trial of ABVD followed by brentuximab vedotin consolidation in limited stage non-bulky Hodgkin lymphoma.
Journal of Clinical Oncology2016-05-204 citations
A Phase 2 Trial of Induction Chemotherapy with ABVD Followed By Brentuximab Vedotin Consolidation in Patients with Previously Untreated Non-Bulky Stage I or II Hodgkin Lymphoma
Blood2014-12-065 citations